NASDAQ:NPCE

NeuroPace News Headlines

$10.36

-0.44 (-4.07%)

(As of 01/14/2022 12:00 AM ET)

Add

Compare

Today's Range: $10.00
▼
$10.86
50-Day Range: $8.63
▼
$16.95
52-Week Range: $8.29
▼
$27.38

Volume: 31,384 shs
Average Volume: 71,576 shs
Market Capitalization: $251.85 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

Get NeuroPace News Delivered to You Automatically

Media Mentions By Week

NeuroPace Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NPCE
News Sentiment
▼
-0.12

0.31
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NPCE Articles
This Week
▼
3

0
▲
NPCE Articles
Average Week

NeuroPace (NASDAQ:NPCE) News Headlines Today

Source

Source	Headline
	NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of "Buy" from Analysts americanbankingnews.com - January 14 at 4:52 AM
	NeuroPace forecasts prelim Q4 revenue of $11M seekingalpha.com - January 11 at 5:25 PM
	NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue finance.yahoo.com - January 11 at 5:25 PM
	NeuroPace (NASDAQ:NPCE) Rating Lowered to Underweight at Morgan Stanley americanbankingnews.com - January 7 at 7:23 PM
	NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference finance.yahoo.com - December 16 at 8:48 AM
	NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy au.finance.yahoo.com - November 12 at 10:07 AM
	NeuroPace, Inc. (NPCE) Q3 2021 Earnings Call Transcript finance.yahoo.com - November 11 at 1:45 PM
	NeuroPace Reports Third Quarter 2021 Financial Results finance.yahoo.com - November 10 at 7:38 PM
	Looking Into NeuroPace's Return On Capital Employed benzinga.com - November 10 at 2:37 PM
	NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021 finance.yahoo.com - October 20 at 7:28 PM
	NeuroPace Announces Addition of Lisa Andrade to the Board finance.yahoo.com - October 19 at 6:03 PM

	Calculating The Fair Value Of NeuroPace, Inc. (NASDAQ:NPCE) finance.yahoo.com - September 20 at 12:40 PM
	NeuroPace to Participate in Upcoming Conferences finance.yahoo.com - August 23 at 6:26 PM
	NeuroPace, Inc. (NPCE) Q2 2021 Earnings Call Transcript finance.yahoo.com - August 13 at 8:37 AM
	NeuroPace Reports Second Quarter 2021 Financial Results finance.yahoo.com - August 12 at 5:35 PM
	NeuroPace Launches nSight Platform and Partnership with Seizure Tracker™ to Provide Doctors With Personalized Information About Their Patients’ Seizure Burden finance.yahoo.com - August 4 at 1:01 PM
	NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021 finance.yahoo.com - July 22 at 7:16 PM
	Have Insiders Been Buying NeuroPace, Inc. (NASDAQ:NPCE) Shares? finance.yahoo.com - July 22 at 2:16 PM
	NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Syndrome finance.yahoo.com - June 30 at 9:43 AM
	NeuroPace Inc. barrons.com - June 9 at 11:53 PM
	NeuroPace Inc to Host Earnings Call finance.yahoo.com - June 3 at 9:37 AM
	NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance finance.yahoo.com - June 3 at 9:37 AM
	NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021 finance.yahoo.com - May 20 at 8:33 AM
	Neuropace, Inc. Rings The Nasdaq Stock Market Closing Bell nasdaq.com - April 28 at 1:05 AM
	NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares markets.businessinsider.com - April 26 at 6:34 PM
	Monday 4/26 Insider Buying Report: NPCE, ODC nasdaq.com - April 26 at 1:34 PM

Get NeuroPace News Delivered to You Automatically

This page was last updated on 1/16/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources